Free Trial
NASDAQ:KZIA

Novogen (KZIA) Stock Price, News & Analysis

Novogen logo
$6.58 -0.05 (-0.75%)
Closing price 03:59 PM Eastern
Extended Trading
$6.39 -0.19 (-2.89%)
As of 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Novogen Stock (NASDAQ:KZIA)

Key Stats

Today's Range
$6.12
$6.60
50-Day Range
$3.22
$9.79
52-Week Range
$2.86
$79.00
Volume
11,729 shs
Average Volume
384,609 shs
Market Capitalization
$6.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$57.50
Consensus Rating
Buy

Company Overview

Novogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

KZIA MarketRank™: 

Novogen scored higher than 65% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Novogen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Novogen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Novogen's stock forecast and price target.
    • Percentage of Shares Shorted

      19.66% of the float of Novogen has been sold short.
    • Short Interest Ratio / Days to Cover

      Novogen has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Novogen has recently increased by 1,261.11%, indicating that investor sentiment is decreasing significantly.
    • Dividend Yield

      Novogen does not currently pay a dividend.

    • Dividend Growth

      Novogen does not have a long track record of dividend growth.

    • Percentage of Shares Shorted

      19.66% of the float of Novogen has been sold short.
    • Short Interest Ratio / Days to Cover

      Novogen has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
    • Change versus previous month

      Short interest in Novogen has recently increased by 1,261.11%, indicating that investor sentiment is decreasing significantly.
    • News Sentiment

      Novogen has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
    • Search Interest

      4 people have searched for KZIA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
    • MarketBeat Follows

      1 people have added Novogen to their MarketBeat watchlist in the last 30 days.
    • Insider Buying vs. Insider Selling

      In the past three months, Novogen insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 1.00% of the stock of Novogen is held by insiders.

    • Percentage Held by Institutions

      Only 30.89% of the stock of Novogen is held by institutions.

    • Read more about Novogen's insider trading history.
    Receive KZIA Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Novogen and its competitors with MarketBeat's FREE daily newsletter.

    KZIA Stock News Headlines

    A new rule goes live in July — and the banks are quietly cashing in
    A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
    Kazia Therapeutics sells IP, trademarks rights to Cantrixil for $1M
    See More Headlines

    KZIA Stock Analysis - Frequently Asked Questions

    Novogen's stock was trading at $8.85 at the beginning of 2025. Since then, KZIA shares have decreased by 25.6% and is now trading at $6.58.
    View the best growth stocks for 2025 here
    .

    Shares of Novogen reverse split on Monday, October 28th 2024.The 1-10 reverse split was announced on Tuesday, October 15th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, October 25th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

    Shares of KZIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Novogen investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW), Meta Platforms (META) and Advanced Micro Devices (AMD).

    Company Calendar

    Today
    7/02/2025
    Fiscal Year End
    6/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:KZIA
    Previous Symbol
    ASX:KZA
    Employees
    12
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $57.50
    High Stock Price Target
    $100.00
    Low Stock Price Target
    $15.00
    Potential Upside/Downside
    +773.9%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    2 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $2.31 million
    Price / Cash Flow
    N/A
    Book Value
    ($9.87) per share
    Price / Book
    -0.67

    Miscellaneous

    Free Float
    997,000
    Market Cap
    $6.63 million
    Optionable
    Optionable
    Beta
    2.63
    7 Energy Stocks to Buy and Hold Forever Cover

    With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

    Get This Free Report

    This page (NASDAQ:KZIA) was last updated on 7/2/2025 by MarketBeat.com Staff
    From Our Partners